You are here

  • Home
  • Archive
  • Volume 2017, Issue
  • Inadvertently boarding a pirate ship: disease progression in a paediatric patient with relapsed metastatic Ewing sarcoma receiving treatment at a centre for alternative therapy in Mexico

Article Text

Article menu
Download PDFPDF
CASE REPORT
Inadvertently boarding a pirate ship: disease progression in a paediatric patient with relapsed metastatic Ewing sarcoma receiving treatment at a centre for alternative therapy in Mexico
  1. Jessica H Cheng1,
  2. Leslie Y Chiang2,
  3. Dennis John Kuo3
  1. 1School of Medicine, University of California, San Diego, La Jolla, California, USA
  2. 2Department of Pediatrics, University of California, San Diego, La Jolla, California, USA
  3. 3Department of Pediatric Hematology-Oncology, University of California, San Diego, San Diego, California, USA
  1. Correspondence to Dr Dennis John Kuo, dekuo{at}ucsd.edu

Summary

Complementary and alternative medicine (CAM) therapies are commonly incorporated into the care of patients with paediatric cancer. Many modalities are safe and effective during cancer treatment and have proved beneficial for symptom relief and quality of life. However, situations where alternative therapy is provided without allopathic medical care supportive care resources can pose a safety risk to patients. This report describes the case of a 16-year-old Chinese girl with metastatic Ewing sarcoma who sought treatment with alternative treatment in Mexico. When her disease progressed with an ensuing significant loss of function, the centre personnel were unable to respond to her acute deterioration or provide necessary medical care. This resulted in her being stranded in a foreign country paralysed, isolated, and with large unanticipated financial expenditures.

https://doi.org/10.1136/bcr-2016-217858

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors The first draft was written by JHC and subsequently reviewed, edited and approved by all the authors.

    • Competing interests None declared.

    • Patient consent Obtained.

    • Provenance and peer review Not commissioned; externally peer reviewed.